MYX

COM:MAYNEPHARMA

Mayne Pharma

  • Stock

Last Close

4.18

22/11 05:10

Market Cap

362.42M

Beta: -

Volume Today

259.52K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
15.41M
-
19.84M
28.71%
30.69M
54.71%
72.67M
136.76%
94.28M
29.73%
91.25M
3.21%
97.17M
6.49%
98.25M
1.11%
105.71M
7.59%
95.80M
9.37%
78.66M
17.89%
average payables
8.82M
-
29.35M
232.88%
93.54M
218.69%
101.05M
8.03%
65.24M
35.44%
57.17M
12.38%
40.14M
29.78%
36.10M
10.06%
52.97M
46.71%
47.80M
9.76%
26.45M
44.66%
average receivables
27.21M
-
47.23M
73.56%
94.19M
99.42%
178.22M
89.22%
242.72M
36.19%
254.65M
4.92%
226.24M
11.15%
189.60M
16.20%
225.76M
19.08%
231.56M
2.57%
208.60M
9.92%
book value per share
5.14
-
9.01
75.48%
9.30
3.19%
18.19
95.62%
16.77
7.81%
13.66
18.51%
13.57
0.70%
9.78
27.93%
6.86
29.82%
7.71
12.32%
5.70
25.99%
capex per share
-1.14
-
-2.42
112.96%
-1.61
33.71%
-15.12
841.22%
-1.29
91.47%
-1.11
13.88%
-0.62
44.53%
-0.32
48.16%
-0.14
54.91%
-2.67
1,752.57%
0.26
109.82%
capex to depreciation
-7.15
-
-9.80
37.06%
-3.85
60.76%
-16.14
319.52%
-1.21
92.48%
-0.15
-
0.30
-
capex to operating cash flow
-1.35
-
-3.73
176.12%
-1.17
68.50%
71.14
6,156.10%
0.80
98.88%
-0.77
196.40%
-0.47
38.55%
-0.43
9.71%
0.06
114.41%
5.14
8,265.40%
-2.18
142.48%
capex to revenue
-0.25
-
-0.60
140.00%
-0.24
60.37%
-1.90
702.97%
-0.18
90.60%
-0.16
12.30%
-0.10
34.00%
-0.06
39.25%
-0.03
55.40%
-1.18
4,133.00%
0.05
104.54%
cash per share
0.52
-
1.78
245.51%
1.30
26.87%
0.97
25.82%
1.29
33.14%
1.21
6.16%
1.80
49.31%
1.25
30.79%
1.17
5.80%
2.67
127.72%
1.90
28.82%
days of inventory on hand
92.24
-
133.35
44.57%
143.70
7.76%
151.20
5.22%
112.62
25.51%
164.54
46.10%
148.21
9.93%
182.01
22.80%
156.64
13.93%
301.56
92.51%
118.80
60.60%
days payables outstanding
38.16
-
306.41
702.91%
500.03
63.19%
94.64
81.07%
87.58
7.46%
82.71
5.56%
47.05
43.11%
75.22
59.85%
91.44
21.56%
116.78
27.72%
33.23
71.55%
days sales outstanding
76.51
-
168.18
119.80%
169.64
0.87%
148.57
12.42%
174.32
17.34%
178.74
2.53%
156.61
12.38%
167.11
6.71%
230.96
38.21%
383.42
66.01%
195.17
49.10%
debt to assets
0.18
-
0.12
35.38%
0.05
57.28%
0.18
256.27%
0.20
15.05%
0.23
10.43%
0.22
3.39%
0.24
8.69%
0.32
35.50%
0.04
88.14%
0.03
18.56%
debt to equity
0.30
-
0.20
34.12%
0.21
7.49%
0.26
22.21%
0.31
16.91%
0.37
20.14%
0.38
4.67%
0.45
17.66%
0.73
62.27%
0.07
89.78%
0.08
4.26%
dividend yield
0.02
-
0.10
419.90%
0.17
-
0.13
-
earnings yield
0.04
-
0.01
72.54%
0.03
108.38%
0.06
127.18%
-0.11
284.90%
-0.37
254.80%
-0.16
57.02%
-0.42
158.97%
-0.67
60.12%
0.32
148.64%
-0.47
245.65%
enterprise value
519.25M
-
647.68M
24.73%
1.52B
134.79%
1.83B
20.52%
1.56B
14.90%
1.04B
33.31%
849.09M
18.36%
751.72M
11.47%
728.48M
3.09%
317.00M
56.48%
295.87M
6.67%
enterprise value over ebitda
12.30
-
21.10
71.64%
20.65
2.17%
8.28
59.89%
12.94
56.21%
9.46
26.88%
9.64
1.93%
9.96
3.30%
7.88
20.85%
-3.25
141.21%
-31.55
870.92%
ev to operating cash flow
19.87
-
28.89
45.41%
28.42
1.62%
-120.28
523.21%
-13.18
89.04%
9.76
174.03%
8.51
12.77%
12.77
50.07%
-3.78
129.58%
-7.42
96.50%
-30.97
317.30%
ev to sales
3.65
-
4.62
26.38%
5.71
23.77%
3.21
43.89%
2.95
8.05%
1.98
32.65%
1.86
6.32%
1.88
0.98%
1.72
8.48%
1.71
0.57%
0.76
55.42%
free cash flow per share
-0.30
-
-1.77
500.52%
-0.24
86.53%
-15.33
6,319.69%
-2.91
81.04%
0.33
111.51%
0.69
105.74%
0.43
37.60%
-2.49
678.88%
-3.19
28.12%
-0.38
88.01%
free cash flow yield
-0.02
-
-0.09
403.22%
-0.01
93.39%
-0.71
11,171.43%
-0.17
76.35%
0.03
119.45%
0.09
175.21%
0.07
24.92%
-0.50
840.97%
-0.72
45.59%
-0.08
88.63%
graham net net
-1.92
-
-2.48
29.15%
-26.02
948.73%
-4.26
83.62%
-3.70
13.18%
-3.94
6.49%
-5.90
49.71%
-5.15
12.65%
-4.60
10.75%
-2.50
45.75%
-4.33
73.35%
graham number
8.91
-
6.75
24.17%
14.13
109.31%
22.49
59.10%
26.29
16.91%
34.39
30.82%
19.43
43.51%
24.20
24.55%
22.67
6.30%
15.72
30.67%
16.76
6.62%
income quality
1.23
-
2.89
135.38%
1.43
50.43%
-0.17
112.01%
0.88
613.43%
0.70
-
0.06
-
intangibles to total assets
0.53
-
0.57
7.89%
0.21
62.73%
0.65
202.20%
0.58
10.71%
0.49
15.39%
0.53
8.16%
0.43
17.54%
0.33
23.65%
0.49
49.08%
0
100%
interest coverage
5.43
-
1.49
72.55%
19.74
1,223.01%
9.87
49.96%
2.06
79.11%
0.89
57.09%
0.11
87.48%
0.23
103.14%
0.35
56.62%
-5.74
1,728.60%
-16.55
188.32%
interest debt per share
1.69
-
1.96
16.21%
2.05
4.35%
4.91
139.62%
5.35
9.07%
5.24
2.00%
5.62
7.11%
4.83
14.10%
5.42
12.25%
0.92
82.97%
0.50
45.30%
inventory turnover
3.96
-
2.74
30.83%
2.54
7.20%
2.41
4.96%
3.24
34.25%
2.22
31.55%
2.46
11.02%
2.01
18.57%
2.33
16.19%
1.21
48.05%
3.07
153.83%
invested capital
0.30
-
0.20
34.12%
0.21
7.49%
0.26
22.21%
0.31
16.91%
0.37
20.14%
0.38
4.67%
0.45
17.66%
0.73
62.27%
0.07
89.78%
199.98M
267,045,462,819.69%
market cap
486.03M
-
645.12M
32.73%
1.49B
131.04%
1.56B
4.36%
1.27B
18.18%
759.67M
40.31%
588.83M
22.49%
502.88M
14.60%
411.49M
18.17%
362.11M
12%
369.44M
2.02%
net current asset value
-40.65M
-
-49.92M
22.81%
-72.51M
45.24%
-173.49M
139.27%
-114.58M
33.96%
-150.31M
31.18%
-291.92M
94.21%
-275.08M
5.77%
-219.19M
20.32%
-59.37M
72.92%
-228.45M
284.82%
net debt to ebitda
0.79
-
0.08
89.42%
0.41
392.35%
1.25
205.62%
2.38
89.97%
2.55
7.17%
2.96
15.89%
3.30
11.56%
3.43
4.05%
0.46
86.52%
7.84
1,596.49%
net income per share
0.69
-
0.22
67.23%
0.95
324.57%
1.24
29.39%
-1.83
248.26%
-3.85
110.02%
-1.24
67.87%
-2.66
115.25%
-3.33
25.10%
1.42
142.80%
-2.19
253.60%
operating cash flow per share
0.84
-
0.65
22.88%
1.37
110.45%
-0.21
115.54%
-1.62
661.20%
1.45
189.33%
1.30
9.73%
0.75
42.59%
-2.34
412.84%
-0.52
77.85%
-0.12
76.88%
payables turnover
9.56
-
1.19
87.55%
0.73
38.72%
3.86
428.36%
4.17
8.06%
4.41
5.89%
7.76
75.78%
4.85
37.44%
3.99
17.74%
3.13
21.71%
10.98
251.44%
receivables turnover
4.77
-
2.17
54.50%
2.15
0.86%
2.46
14.18%
2.09
14.77%
2.04
2.47%
2.33
14.13%
2.18
6.29%
1.58
27.65%
0.95
39.76%
1.87
96.46%
research and ddevelopement to revenue
0.03
-
0.04
24.38%
0.03
17.63%
0.01
55.87%
0.02
60.65%
0.05
111.82%
0.05
10.07%
0.05
12.86%
0.03
26.78%
0.08
145.14%
0.05
38.55%
return on tangible assets
0.17
-
0.03
79.89%
0.03
11.18%
0.13
327.41%
-0.17
232.47%
-0.34
95.94%
-0.11
67.62%
-0.25
130.76%
-0.32
25.94%
0.19
158.44%
-0.15
181.90%
revenue per share
4.58
-
4.07
11.27%
6.80
67.29%
7.98
17.22%
7.23
9.30%
7.10
1.80%
5.97
15.95%
5.09
14.67%
5.15
1.10%
2.25
56.24%
4.88
116.39%
roe
0.13
-
0.02
81.33%
0.10
311.45%
0.07
33.85%
-0.11
260.82%
-0.28
157.74%
-0.09
67.64%
-0.27
198.65%
-0.49
78.26%
0.18
138.10%
-0.38
307.55%
roic
0.09
-
0.02
81.58%
0.08
372.55%
0.05
32.14%
0.02
65.03%
0.01
49.72%
0.00
81.21%
0.01
203.44%
0.01
181.28%
-0.28
2,027.52%
-0.14
49.28%
sales general and administrative to revenue
0.18
-
0.21
14.39%
0.19
9.13%
0.14
26.15%
0.14
3.95%
0.16
8.96%
0.14
13.43%
0.07
45.53%
-0.07
191.64%
0.20
396.76%
shareholders equity per share
5.14
-
9.01
75.48%
9.30
3.19%
18.19
95.62%
16.77
7.81%
13.66
18.51%
13.57
0.70%
9.78
27.93%
6.86
29.82%
7.71
12.32%
5.70
25.99%
stock based compensation to revenue
tangible asset value
18.16M
-
19.24M
5.96%
43.74M
127.30%
76.98M
76.01%
180.63M
134.64%
216.44M
19.83%
80.02M
63.03%
135.43M
69.23%
129.61M
4.30%
17.10M
86.81%
454.19M
2,556.69%
tangible book value per share
0.59
-
0.56
4.73%
1.12
100.45%
1.07
3.94%
2.47
129.95%
2.93
18.83%
1.05
64.34%
1.72
64.70%
1.57
8.63%
0.21
86.81%
5.70
2,646.05%
working capital
35.52M
-
61.74M
73.84%
52.73M
14.60%
229.11M
334.53%
300.87M
31.32%
260.62M
13.38%
271.69M
4.25%
194.00M
28.60%
-98.80M
150.93%
242.67M
345.61%
146.66M
39.57%

All numbers in (except ratios and percentages)